Alterity Therapeutics Limited
Compounds for and methods of treating diseases

Last updated:

Abstract:

The present invention provides heterocyclic compounds of formula (I) that modulate biological metals and to pharmaceutical compositions containing such compounds. The invention particularly relates to compounds that modulate iron and to compounds for the treatment of diseases, particularly neurological diseases such as Parkinson's disease (PD), Alzheimer's disease (AD), Alzheimer-type dementia, Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and multiple system atrophy (MSA). ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

23 Apr 2021

Issue date:

26 Oct 2021